Quantum dot-infused nanocomposites: revolutionizing diagnostic sensitivity.

Journal: Nanoscale
Published Date:

Abstract

Quantum dot-doped nanocomposites (QDNCs) represent an innovative breakthrough in diagnostic medicine, enabling ultra-sensitive and accurate detection at disease onset. Utilizing the size-tunable optical properties, high quantum yield, and photostability of quantum dots (QDs), these materials enable the highly sensitive identification of biomarkers at femtomolar concentrations in complex biological environments. The incorporation of QDs into nanocomposites enables them to achieve better diagnostic modes such as targeted delivery, signal amplification, and multifunctionality, with numerous applications in cancer diagnosis, infectious disease diagnosis, and real-time glucometry. Core-shell and hybrid architectures of advanced materials also enhance the stability and biocompatibility of the QDs. Surface functionalization enhancements and green synthesis approaches have alleviated the issues of toxicity and scalability, with the material now being fit for use in the clinical arena. Furthermore, the amalgamation of QDNCs with machine learning is promising for intelligent diagnostic tools capable of real-time analysis and personalized medicine. This review investigates the engineering of QDNCs, their transformative role in healthcare diagnostics, and their potential to revolutionize point-of-care devices. The capability to address significant translational challenges concerning biocompatibility, toxicity, and scalability will enable QD-based technologies to set a new standard for precision diagnostics, ushering in new advancements in global healthcare.

Authors

  • Zahra Amiri
    Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd 74877-94149, Iran. zahra.amiri.de@gmail.com.
  • Parsa Taromi
    Department of Chemistry, Iran University of Science and Technology, Tehran, Iran. parsa_taromipt@yahoo.com.
  • Keyvan Alavi
    Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran. Keivan.alavi@gmail.com.
  • Parto Ghahramani
    Kermanshah University of Medical Sciences, Regenerative Medicine Research Center, Iran. partoghahramani@gmail.com.
  • William C Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China. williamcscho@gmail.com.
  • Marzieh Ramezani Farani
    NanoBio High-Tech Materials Research Center, Department of Biological Sciences and Bioengineering, Inha University, Incheon 22212, Republic of Korea. farani.marzi@inha.ac.kr.
  • Yun Suk Huh
    Department of Biological Engineering, Inha University, Incheon, Republic of Korea.

Keywords

No keywords available for this article.